Home
Live Updates
Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures : comparemela.com
Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.
Related Keywords
Heidi Zakoul ,
Supreme Court ,
Drug Administration ,
Creative Commons Attribution License ,
Editorial Board ,
Teratogen Information System ,
Female Contraception ,
Medical Risk Factors ,
Pregnancy ,
Contraceptive Therapy ,
Contraception ,
Drug Therapy ,
Miscarriage ,
comparemela.com © 2020. All Rights Reserved.